OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2021
(4)
2022
(3)
2016
(2)
2025
(1)
2015
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG.
Not available
S-EPMC4217540
|
biostudies-literature
Cite
Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infection.
Not available
S-EPMC4773807
|
biostudies-literature
Cite
Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF.
Not available
S-EPMC4534677
|
biostudies-literature
Cite
Impaired expression of the COSMOC/MOCOS gene unit in ASD patient stem cells.
Not available
S-EPMC8159765
|
biostudies-literature
Cite
Deletion of
Mocos
Induces Xanthinuria with Obstructive Nephropathy and Major Metabolic Disorders in Mice.
Not available
S-EPMC8785848
|
biostudies-literature
Cite
Olfactory stem cells reveal MOCOS as a new player in autism spectrum disorders.
Not available
S-EPMC4995547
|
biostudies-literature
Cite
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327
|
biostudies-literature
Cite
Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE.
Not available
S-EPMC12681984
|
biostudies-literature
Cite
A first update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC9352569
|
biostudies-literature
Cite
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
Not available
S-EPMC9060606
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets